Repligen Corporation

Historical 13F Holders

Symbol
RGEN
CUSIP
759916109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 759916109 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 1
13.0% 10/7/2026
Event 9/30/2026
Price T Rowe Associates Inc /MD/ 13G/A Amendment 8 3.1% 8/14/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Vanguard Group Inc 13G/A Amendment 7 0% 3/27/2026
Event 3/13/2026
Price T Rowe Associates Inc /MD/ 13G/A Amendment 7 8.2% 2/17/2026
Event 12/31/2025
Roy T. Eddleman Living Trust 13G/A Amendment 8
4.8% 2/13/2026
Event 12/31/2025
FMR LLC 13G
5.1% 2/5/2026
Event 12/31/2025
Price T Rowe Associates Inc /MD/ 13G/A Amendment 6 6.1% 9/8/2025
Event 8/31/2025
BlackRock, Inc. 13G/A Amendment 4 9.3% 4/24/2025
Event 3/31/2025
Price T Rowe Associates Inc /MD/ 13G/A Amendment 5 12.7% 2/14/2025
Event 12/31/2024
Eddleman Roy T 13G/A Amendment 7
4.8% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 38 2.44 M $468 M
2026 Q2 501 74.4 M $9.07 B
2026 Q1 458 65.5 M $7.76 B
2025 Q4 495 62.5 M $10.2 B
2025 Q3 485 60.8 M $8.08 B
2025 Q2 470 59.0 M $7.24 B
2025 Q1 462 58.1 M $7.38 B
2024 Q4 454 56.6 M $8.09 B
2024 Q3 470 55.9 M $8.31 B
2024 Q2 479 56.9 M $7.17 B
2024 Q1 516 57.7 M $10.6 B
2023 Q4 496 59.2 M $10.6 B
2023 Q3 466 57.3 M $9.39 B
2023 Q2 473 54.8 M $7.76 B
2023 Q1 472 54.6 M $9.13 B
2022 Q4 464 55.5 M $9.39 B
2022 Q3 452 51.1 M $9.57 B
2022 Q2 420 50.4 M $8.19 B
2022 Q1 473 48.9 M $9.17 B
2021 Q4 535 47.3 M $12.5 B
2021 Q3 503 47.3 M $13.6 B
2021 Q2 448 46.7 M $9.31 B
2021 Q1 477 45.7 M $8.88 B
2020 Q4 470 46.4 M $8.87 B
2020 Q3 414 44.8 M $6.61 B
2020 Q2 389 52.3 M $5.84 B
2020 Q1 325 48.0 M $5.37 B
2019 Q4 325 44.4 M $4.10 B
2019 Q3 320 45.0 M $3.45 B
2019 Q2 293 47.5 M $4.08 B
2019 Q1 264 40.5 M $2.39 B
2018 Q4 253 40.4 M $2.13 B
2018 Q3 216 42.4 M $2.35 B
2018 Q2 206 41.3 M $2.01 B
2018 Q1 194 38.8 M $1.41 B
2017 Q4 191 37.9 M $1.37 B
2017 Q3 207 36.5 M $1.40 B
2017 Q2 208 35.6 M $1.47 B
2017 Q1 189 33.2 M $1.17 B
2016 Q4 191 32.4 M $998 M
2016 Q3 188 31.9 M $963 M
2016 Q2 196 30.5 M $837 M
2016 Q1 196 29.6 M $794 M
2015 Q4 190 30.7 M $867 M
2015 Q3 196 30.4 M $846 M
2015 Q2 179 30.3 M $1.25 B
2015 Q1 179 29.6 M $898 M
2014 Q4 175 29.1 M $577 M
2014 Q3 175 28.4 M $565 M
2014 Q2 174 28.5 M $650 M
2014 Q1 148 26.6 M $343 M